The Feasibility of Pop-Dusting Using High-Power Laser (2 J × 50 Hz) in Retrograde Intrarenal Surgery for Renal Stones: Retrospective Single-Center Experience
Overview
Urology
Affiliations
Recently, retrograde intrarenal surgery (RIRS) using laser lithotripsy has become popular. However, the optimal laser energy setting for pop-dusting has not been established. In this study, we report our experiences of RIRS using the high-power (up to 100 W) pop-dusting (HPPD) technique. This study retrospectively assessed 82 cases with RIRS using HPPD. Patients who underwent abdominal CT or mercaptoacetyltriglycine (MAG3) diuretic renal scan at 3 months postoperatively were included in this study. Patient and stone characteristics and perioperative and postoperative outcomes were evaluated. The average number of renal stones was 3.67 ± 4.11, and the average length of the largest stones was 13.30 ± 6.41 mm. The mean Hounsfield units was 959.99 ± 384.73. The operation time was 58.10 ± 26.67 minutes. The mean HPPD time was 11.93 ± 9.48 minutes, with settings of 1.97 ± 0.25 J and 48.78 ± 3.29 Hz. The stone-free rate was 89%. The mean hospital stay was 1.68 ± 1.29 days. Pelvicaliceal and ureter injuries were observed in 9.8% and 32.9% of the study population, respectively. However, there was no transfusion, subcapsular hematoma, persistent urinary leakage, ureteral or infundibular stricture, or renal functional deterioration. There was transient postoperative fever in 12.2% of the study population. HPPD could be performed safely during RIRS for renal stones without significant complications such as collecting system injury or bleeding. High-power laser mode (up to 100 W) can be a safe and effective choice for pop-dusting during RIRS, especially for large and hard stones.
Nedbal C, Yuen S, Akram M, Keller E, Ballesta Martinez B, Philip J World J Urol. 2024; 42(1):560.
PMID: 39361036 DOI: 10.1007/s00345-024-05275-9.
Yuen S, Traxer O, Wroclawski M, Gadzhiev N, Chai C, Lim E Diagnostics (Basel). 2024; 14(10).
PMID: 38786332 PMC: 11120421. DOI: 10.3390/diagnostics14101034.
Tsaturyan A, Keller E, Peteinaris A, Gabriel F, Pietropaolo A, Ballesta Martinez B World J Urol. 2024; 42(1):240.
PMID: 38630158 DOI: 10.1007/s00345-024-04926-1.
Faria-Costa G, Tsaturyan A, Peteinaris A, Pagonis K, Faitatziadis S, Gkeka K Cent European J Urol. 2023; 76(3):233-238.
PMID: 38045785 PMC: 10690379. DOI: 10.5173/ceju.2023.03.
Kronenberg P, Cerrato C, Juliebo-Jones P, Herrmann T, Tokas T, Somani B World J Urol. 2023; 41(12):3817-3827.
PMID: 37906263 DOI: 10.1007/s00345-023-04669-5.